G protein-coupled receptor kinase 5 (GRK5) is a regulator of cardiac performance and a potential therapeutic target in heart failure in the adult. Additionally, we have previously classified GRK5 as a determinant of left-right asymmetry and proper heart development using zebrafish. We thus aimed to identify GRK5 variants of functional significance by analysing 187 individuals with laterality defects (heterotaxy) that were associated with a congenital heart defect (CHD). Using Sanger sequencing we identified two moderately frequent variants in GRK5 with minor allele frequencies <10%, and seven very rare polymorphisms with minor allele frequencies <1%, two of which are novel variants. Given their evolutionarily conserved position in zebrafish, in-depth functional characterisation of four variants (p.Q41L, p.G298S, p.R304C and p.T425M) was performed. We tested the effects of these variants on normal subcellular localisation and the ability to desensitise receptor signalling as well as their ability to correct the left-right asymmetry defect upon Grk5l knockdown in zebrafish. While p.Q41L, p.R304C and p.T425M responded normally in the first two aspects, neither p.Q41L nor p.R304C were capable of rescuing the lateralisation phenotype. The fourth variant, p.G298S was identified as a complete loss-of-function variant in all assays and provides insight into the functions of GRK5.
1 August 2012 in European Journal of Medical Genetics
Split-hand/foot malformation (SHFM) shows diverse heterogeneity and manifests with reduced penetrance and variable expressivity. This study investigated the underlying genetic cause of a family segregating SHFM. Exome sequencing followed by Sanger sequencing identified a novel single nucleotide heterozygous variant (NC_000019.9 (NM_005499.3):c.1118del) in UBA2 cosegregating in the family in an autosomal dominant manner. Our findings conclude that reduced penetrance and variable expressivity are the two remarkable and unusual features of SHFM.
30 July 2021 in World Journal of Advanced Research and Reviews
The present study evaluates the phytochemical screening, analgesic and anti-inflammatory properties of aqueous and methanolic extracts from the root of Oligomeris linifolia (OL). Pain responses were studied in mice using acetic acid writhing method and in rats using the hot plate and formalin test. The effect of the extract on edema induced by 1.5% carrageenan was also investigated. The extracts of OL exhibited significant anti-nocicetive properties against acetic acid induced abdominal constrictions in mice. In the rat the extract exhibited significant analgesic activity as evidence by (i) increased escaped latency on hot plate in the extract-treated rats and (ii) reduction in formalin-induced pain. The maximum edema rates attained in the rats pre-treated with 150mg/kg of aqueous and methanol extracts of OL (12.50 ± 2.88%, P<0.005 and 21.63 ± 3.21%, P<0.05 respectively) were significantly lower than the control value (32.62 ± 5.33%). Aspirin (150mg/kg) gave a maximum edema rate of 13.04 ± 1.98% (P<0.005). The results provide preliminary evidence for the anecdotal use of Oligomeris linifolia by traditional medical practitioners in the management of pain and inflammation.